These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24026037

  • 1. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
    Kim EJ, Song WH, Lee JU, Shin MS, Lee S, Kim BO, Hong KS, Han SW, Park CG, Seo HS.
    Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037
    [Abstract] [Full Text] [Related]

  • 2. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J, Barbosa L, Silva JA, Bertoquini S.
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [Abstract] [Full Text] [Related]

  • 3. Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension.
    Ihm SH, Jeon HK, Chae SC, Lim DS, Kim KS, Choi DJ, Ha JW, Kim DS, Kim KH, Cho MC, Baek SH, BELASCO trial investigators, Republic of Korea.
    Chin Med J (Engl); 2013 Oct; 126(11):2021-8. PubMed ID: 23769551
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges.
    Pucci G, Battista F, Schillaci G.
    Hypertens Res; 2014 Jan; 37(1):10-2. PubMed ID: 24048493
    [No Abstract] [Full Text] [Related]

  • 5. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
    Koumaras C, Tziomalos K, Stavrinou E, Katsiki N, Athyros VG, Mikhailidis DP, Karagiannis A.
    J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
    [Abstract] [Full Text] [Related]

  • 6. Is validation of non-invasive hemodynamic measurement devices actually required?
    Salvi P.
    Hypertens Res; 2014 Jan; 37(1):7-9. PubMed ID: 24048491
    [No Abstract] [Full Text] [Related]

  • 7. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 8. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.
    Drugs R D; 2011 Feb; 11(2):171-90. PubMed ID: 21679007
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P, Omvik P, Nordrehaug JE, White W.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [Abstract] [Full Text] [Related]

  • 10. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
    Bhatt AB, Buck JS, Zuflacht JP, Milian J, Kadivar S, Gauvreau K, Singh MN, Creager MA.
    Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
    [Abstract] [Full Text] [Related]

  • 11. Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters?
    Davies J, Carr E, Band M, Morris A, Struthers A.
    J Renin Angiotensin Aldosterone Syst; 2005 Dec; 6(3):151-3. PubMed ID: 16525946
    [Abstract] [Full Text] [Related]

  • 12. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 13. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T, Ikeda M, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T.
    J Cardiovasc Pharmacol; 1987 Feb; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [Abstract] [Full Text] [Related]

  • 14. Use of carvedilol in hypertension: an update.
    Leonetti G, Egan CG.
    Vasc Health Risk Manag; 2012 Feb; 8():307-22. PubMed ID: 22661898
    [Abstract] [Full Text] [Related]

  • 15. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):189-95. PubMed ID: 22462558
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):712-9. PubMed ID: 15734615
    [Abstract] [Full Text] [Related]

  • 18. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
    Wright JT, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.
    J Clin Hypertens (Greenwich); 2007 Nov 01; 9(11):842-9. PubMed ID: 17978591
    [Abstract] [Full Text] [Related]

  • 19. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1987 Nov 01; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [Abstract] [Full Text] [Related]

  • 20. Circadian antihypertensive profile of carvedilol (BM 14190).
    Meyer-Sabellek W, Schulte KL, Distler A, Gotzen R.
    J Cardiovasc Pharmacol; 1987 Nov 01; 10 Suppl 11():S119-23. PubMed ID: 2454357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.